MEDICINE DETAILS
Tavlesse
Active ingredient: Fostamatinib Disodium Hexahydrate
Tavlesse is recorded in this directory with the active ingredient Fostamatinib Disodium Hexahydrate. This page brings together catalogue strength, dosage-form and pack records so they can be checked against a prescription.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Tavlesse used for?
Tavlesse (fostamatinib) is indicated for the treatment of chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments.
Fostamatinib is a SYK (spleen tyrosine kinase) inhibitor indicated in adult patients with ITP who have had an insufficient response to a previous treatment. It is a targeted agent that reduces the immune system’s destruction of platelets, which are critical for blood clotting and healing.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Tavlesse identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
100 mg film-coated tablets · 60 tablets Catalogue organisation: Orifarm GmbH
-
150 mg film-coated tablets · 60 tablets Catalogue organisation: kohlpharma GmbH
OFFICIAL SOURCES
Check the Tavlesse record at an official source.
Search for “Tavlesse” or “Fostamatinib Disodium Hexahydrate”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Tavlesse.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Tavlesse
01What is Tavlesse?+
This directory record associates the brand name Tavlesse with the active ingredient Fostamatinib Disodium Hexahydrate. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Tavlesse strengths and packs are recorded?+
The catalogue currently shows: 100 mg film-coated tablets · 60 tablets; 150 mg film-coated tablets · 60 tablets. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Tavlesse?+
Catalogue records currently name: Orifarm GmbH, kohlpharma GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?+
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Tavlesse?+
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Tavlesse, payment request, stock guarantee or binding offer.
06Can I buy Tavlesse from this website?+
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.